Lintong Li

Statistics

Publications

Citations

403

H-Index

Active since

2006

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Lintong Li is an author at Genomics Institute of the Novartis Research Foundation specializing in oncology, targeted cancer therapy, and molecular oncology.

Publications per year

2006–2020

Publications

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

Anna Galkin, Jonathan S. Melnick, Sung Joon Kim et al. · Proceedings of the National Academy of Sciences · 2006 · 377 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Efficacy and Tolerability of Pyrazolo[1,5-<i>a</i>]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma

Casey J. N. Mathison, D. CHIANELLI, Paul V. Rucker et al. · ACS Medicinal Chemistry Letters · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +14

1–2 of 2